Literature DB >> 11578952

Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design.

V Apostolopoulos1, I F McKenzie, I A Wilson.   

Abstract

The major histocompatibility complex presents antigenic peptides on the surface of antigen presenting cells to T cell receptors. Recognition of peptide-MHC by T cells initiates a cascade of signals in T cells which maintains a T cell dependent immune response. An understanding of the how peptides bind to MHC class I molecules is an important prerequisite in the design of vaccines. Herein, we will discuss, with special emphasis on MUC1, unusual features of MUC1 peptide binding to MHC class I, obtained from vaccine studies including a MUC1 peptide mimic and the crystal structures of low and high affinity peptides lacking canonical anchor motifs in complex with H-2Kb.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578952     DOI: 10.2741/apostol

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  3 in total

1.  Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.

Authors:  Eliada Lazoura; Jodie Lodding; William Farrugia; Paul A Ramsland; James Stevens; Ian A Wilson; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

2.  Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.

Authors:  Xiao-Li Huang; Zheng Fan; Bonnie A Colleton; Rico Buchli; Hongyi Li; William H Hildebrand; Charles R Rinaldo
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.

Authors:  Dapeng Zhou; Lan Xu; Wei Huang; Torsten Tonn
Journal:  Molecules       Date:  2018-05-31       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.